Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
American Journal of Hematology|June 24, 2015
Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Seminars in Hematology|April 3, 2010
Status of ongoing collaborative effortsJulie M Vose
The Oncologist|March 30, 2004
Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphomaJulie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
2016 ASCO Presidential Address: "Collective Wisdom: The Future of Patient-Centered Care and Research"Julie M Vose
Clinical Advances in Hematology & Oncology : H&O|May 24, 2014
Commentary: diagnostic dilemmas that impact treatment decisions in lymphomaJulie M Vose
American Journal of Hematology|May 23, 2012
Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Lancet (London, England)|December 24, 2019
Chemoimmunotherapy for localised low-risk diffuse large B-cell lymphomaJulie M Vose
Oncology (Williston Park, N.Y.)|January 14, 2021
Looking Toward a Bright Future: 2020 ASH Virtual Meeting Delivers Promising DataJulie M Vose
American Journal of Hematology|July 13, 2017
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Oncology (Williston Park, N.Y.)|September 23, 2015
Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer ResearchJulie M Vose
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
American Journal of Hematology|June 24, 2015
Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Seminars in Hematology|April 3, 2010
Status of ongoing collaborative effortsJulie M Vose
The Oncologist|March 30, 2004
Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphomaJulie M Vose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
2016 ASCO Presidential Address: "Collective Wisdom: The Future of Patient-Centered Care and Research"Julie M Vose
Clinical Advances in Hematology & Oncology : H&O|May 24, 2014
Commentary: diagnostic dilemmas that impact treatment decisions in lymphomaJulie M Vose
American Journal of Hematology|May 23, 2012
Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Lancet (London, England)|December 24, 2019
Chemoimmunotherapy for localised low-risk diffuse large B-cell lymphomaJulie M Vose
Oncology (Williston Park, N.Y.)|January 14, 2021
Looking Toward a Bright Future: 2020 ASH Virtual Meeting Delivers Promising DataJulie M Vose
American Journal of Hematology|July 13, 2017
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical managementJulie M Vose
Oncology (Williston Park, N.Y.)|September 23, 2015
Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer ResearchJulie M Vose
Pageof 30